J&J seeks EU approval for new Darzalex multiple myeloma indication

J&J submitted a new application to the EMA for the approval of its Darzalex combination therapy for multiple myeloma.

Mar 7, 2024 - 18:00

J&J seeks EU approval for new Darzalex multiple myeloma indication

J&J submitted a new application to the EMA for the approval of its Darzalex combination therapy for multiple myeloma.

Read the original article

Tags:

Previous Article

Alumis secures $259m to develop therapies for immune dysfunction

Avacta Group files patent for extended circulating serum half-life therapeutic c...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: New NIH head says government has fallen behind pharma on clinical trials

STAT+: New NIH head says government has fallen behind p...

Nov 15, 2023

Trump surgeon general admits Trump White House made mistakes during Covid

Trump surgeon general admits Trump White House made mis...

Sep 8, 2023

Cambridge biotech Thymmune wins $37m NIH grant for thymic cell therapies

Cambridge biotech Thymmune wins $37m NIH grant for thym...

Sep 29, 2023